Story Cannabis CEO: Investors still hesitant despite rescheduling of support from presidential candidates. | Where to order Skittles Moonrock online
Learn how to buy weed online. TOP QUALITY GRADE A++
Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.
👉 Click here to Visit our shop! 🛒
Story’s CEO said that whoever wins the presidential elections in November, there are “some good and some bad” with both.
Jason Vedadi is the CEO of Arizona’s multistate operator Story Cannabis. He told us that the U.S. cannabis sector is poised to make some historic gains in the coming presidential election. However, this hasn’t translated to investor confidence or an increase in capital raises. Green Market Report.
Vedadi began by pointing out how mainstream marijuana has become, now that Vice President Kamala Harris as well as former President Donald Trump are formally in favor of it. Go on record Supporting cannabis rescheduling which, once completed, should save the industry Billions of dollars a year Tax write-offs are available.
The most positive thing about this is that both parties seem to be pro-rescheduling. Vedadi said that we’re losing the prohibitionist mindset of prosecuting people for cannabis.
Vedadi believes that the cannabis industry won’t get all it wants from Washington, D.C., over the next few months. He warned that it is likely the GOP will retake the U.S. Senate and that a Harris victory would mean more partisan gridlock on issues such as the SAFER Banking Act.
Vedadi said that if Trump is elected, a new Republican cabinet could include prohibitionists, just like the former Attorney General Jeff Sessions During the first Trump presidency
Vedadi said, “I think there’s good and bad in both of them. In the past I think it was just good or bad.”
“See it to Believe it”
Vedadi, when asked if Trump’s endorsement gave him more ammunition to raise money, said that the benefits of rescheduling are yet to be felt by the investor class.
Vedadi said that the industry had been disappointed in previous Congressional sessions when it was promised substantive reforms. You will be disappointed Especially with banking access, it is important to act quickly.
Vedadi said, “There is just too much’see it to be believed’ in our industry today.” “You can see it in the stock prices.” These stocks were almost double what they are today two years ago. Their company performances have improved, and there are more positive outlooks and multiple catalysts. But we are still not seeing rational valuation summary, from a public market perspective. It leads me to believe the general investing market still believes that once you guys show us what actually happens, then we will come in. ‘”
Vedadi is “optimistic” and believes that the rescheduling of the 280E tax relief and the accompanying tax relief will arrive within the first quarter or half of 2025.
“I’m pretty optimistic. Vedadi said, “I haven’t seen any evidence that would indicate the DEA was stalling.” “By actually This hearingI feel that this shows that they are not willing to make any mistakes. I feel that the government is not being dishonest.”
Vedadi stated that Story Cannabis would save tens or even hundreds of millions of dollars in tax payments each year once 280E is no longer applicable to state-legal marijuana business. He added that this would be more for larger MSOs with larger footprints. The benefits of rescheduling, and the removal of the 280E burden will be multiple.
“That allows us the ability to lower our prices and bring down our margins, without worrying about how to make money by creating margins. Vedadi said that you could give up your tax savings to increase your revenue and then take on the black market because you are more competitive.
He said that the Sun Belt is Story’s next goal, as it is arguably the last frontier for legal marijuana. Vedadi said Story Cannabis has its eye on Alabama, Georgia, Kentucky and North Carolina.
Vedadi said, “We want to establish ourselves as a medical business early before the state matures and rec.” “We’re more focused on the emergence of a market rather than the mature ones,” Vedadi said.
Leave a Reply
Want to join the discussion?Feel free to contribute!